McDermott Will & Emery Represents Innate Pharma in Acquisition of Anti-C5aR

Emmanuelle Trombe, Bertrand Delafaye,Marion Abecassis, Antoine Vergnat and Côme de Saint-Vincent represented Innate Pharma, a clinical-stage biotechnology company, in its purchase of Anti-C5aR from Novo Nordisk A/S, a global healthcare company.